Deep learning for sparse data Intellegens first commercial product, Alchemite?, has been licensed to drug discovery customer and we are in negotiations to deploy with other customers. The technology allows for the generation of models from sparse data resulting in predictive models that can be integrated with customers own systems and workflows. We are also developing a web based tool to allow for easier interaction with core algorithm and is on trial with a number of customers. Alchemite? is the first in a series of application specific AI modules that we are developing. These modules will be designed to address specific, high value, data analysis bottlenecks that we are uncovering through our discussions with existing and potential customers. New modules will look at noisy data, time series data and collaborative learning modules.
Member count: 1-10

Mentions in press and media 3

04.08.2020DIGIT Deal...Investment Eos Advisory and
20.09.2018Novel deep...Novel deep learning drug disco...--cambridgen...
06.12.2017New Cambri...New Cambridge spin-out, Intell...--cambridgen...